-

SHAREHOLDER ALERT: Robbins LLP Announces That Ontrak, Inc. (OTRK) is Being Sued for Misleading Shareholders

SAN DIEGO & SANTA MONICA, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Ontrak, Inc. (NASDAQ: OTRK) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities Exchange Act of 1934 between November 5, 2020 and February 26, 2021. Ontrak is a healthcare company that offers a Predict-Recommend-Engage platform that organizes and automates healthcare data integration and analytics. Ontrak programs provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions.

If you suffered a loss due to Ontrak Inc.'s misconduct, click here.

Ontrak, Inc. (OTRK) Misled Investors About the Impact Losing its Largest Customer Would Have on its Financial Results

According to the complaint, Ontrak failed to disclose that: (1) its largest customer evaluated the Company on a provider basis, valuing Ontrak’s performance based on achieving the lowest cost per medical visit rather than clinical outcomes or medical cost savings; (2) as a result, Ontrak’s largest customer did not find the Company’s program to be effective and was reasonably likely to terminate its contract with Ontrak; and (3) because this customer accounted for a significant portion of the Company's revenue, the loss of the customer would have an outsized impact on Ontrak's financial results.

On March 1, 2021, Ontrak announced its preliminary financial results for fourth quarter and full year 2020 and shared that its largest customer had terminated its contract with Ontrak effective June 26, 2021. Apparently, "the customer evaluated [Ontrak's] performance based on [its] ability to achieve the lowest possible cost per medical visit, and not on [its] clinical outcomes data or medical cost savings, which were meaningful and significant." Further, "the coaching model which Ontrak has pioneered for over a decade was seen by the customer as less relevant to their performance metrics." On this news, Ontrak's share price fell $27.32, or more than 46% to close at $31.62 per share on March 2, 2021.

If you purchased shares of Ontrak, Inc. (OTRK) between November 5, 2020 and February 26, 2021, you have until May 3, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Ontrak, Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Reminds Primo Brands Corporation Stockholders on the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the PRMB class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Primo Brands Corporation (NYSE: PRMB) purports to be a leading North American branded beverage company focused on healthy hydration, offering responsibly sourced products across multiple formats, channels, and price points, and for a wide range of consumer occasions. Its products are distributed in every U.S. state and in Canada. Who is part of the class? The case purportedly represents stockholders who purchased or otherwise acquired (i) the co...

Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. What is the class period? February 21, 2025 - August 28, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or acquired Telix securities during the class peri...

Robbins LLP Reminds Freeport-McMoran Inc. Stockholders of the January 12, 2026 Lead Plaintiff Deadline – Contact us today for information about the FCX class action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Freeport-McMoran Inc. (NYSE: FCX) is a mining company. What is the class period? February 15, 2022 - September 24, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Freeport during the class period because the Company allegedly misled investors regarding safety at its mines. For more information, submit a form, email attorney Aaron Dumas, Jr....
Back to Newsroom